Can a protocol be signed electronically?

Yes. Electronic signatures are legally recognized under the federal ESIGN Act (15 U.S.C. ch. 96) and by UETA in most states, provided the signature shows intent, consent, attribution, and record retention.

When is notarization required?

Most protocols do not require notarization, but specific institutional or sponsor requirements may. If a notarized signature is requested, follow state rules and consider Remote Online Notarization where allowed.

What if the IRB requests amendments?

Submit an amendment with tracked changes and a cover memo. Include revised consent forms, a redline of changes, and a rationale to minimize review time.

How long must the protocol be retained?

Retain the final protocol and all versions per institutional policy, generally at least 3 years after study close; HIPAA and other rules may require 6 or more years.

Who may sign the protocol?

Authorized signatories typically include the principal investigator, department chair, and institutional official; list required signers in the protocol and follow institutional delegation logs.

Is eConsent acceptable for participants?

Electronic consent is permitted when it meets ESIGN/UETA requirements and institutional policies; consumer-disclosure elements and the ability to provide a paper copy when requested may be required for some studies.

Electronic Signature
Templates
Miscellaneous
Research Review Protocol

Research Review Protocol

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

RESEARCH REVIEW PROTOCOL

Recitals

WHEREAS, Principal Investigator: represents responsibility for the design and conduct of the research described in this Protocol; and

WHEREAS, Reviewing Body/Institution: has authority to review and approve research involving human subjects affording protections and oversight; and

WHEREAS, the parties desire to set forth the protocol, review conditions, oversight responsibilities, compensation for review (if any), confidentiality protections and termination rights governing the research described herein.

Protocol Identification

Protocol Title Protocol Number / Version Institution / Department

Administrative Information

Principal Investigator Contact Sponsor / Funding Source

Type of Review: Full Board Expedited Exempt

Scope of Work

Describe the specific tasks, responsibilities, oversight and deliverables that are part of this protocol review and the conduct of the research. Include who performs each task and required deliverables.

Scientific Summary

Objectives Study Design / Methods Study Population

Consent, Risks, Data and Safety

Consent Process Risk Assessment & Mitigation Data Collection, Storage & Retention Safety Monitoring & Reporting Requirements

Payment Terms

Compensation for review, oversight, or related services (if applicable) shall be set forth as follows.

Total Amount Payable (USD) Payment Schedule Late Fee

Term and Termination

Effective Date: Termination Date:

Notice Period Prior to Termination (days):

Either party may terminate this Protocol for material breach by the other party if the breaching party fails to cure such breach within the notice period specified above. Termination does not relieve either party of obligations accrued prior to termination, including reporting and confidentiality obligations.

Confidentiality

Each party shall treat as Confidential Information all non-public, proprietary, personal, or health information disclosed in connection with this Protocol or the research. Confidential Information includes individually identifiable health information, proprietary study materials, and unpublished data. The receiving party shall (a) use Confidential Information solely for performance under this Protocol, (b) restrict access to personnel with a need to know, (c) implement reasonable administrative, technical and physical safeguards to protect confidentiality, and (d) not disclose Confidential Information except as required by law or as authorized in writing by the disclosing party. Upon termination, the receiving party shall return or destroy Confidential Information as instructed by the disclosing party, except where retention is required by law or institutional policy.

Compliance, Reporting and Amendments

The Principal Investigator shall ensure ongoing compliance with applicable laws, institutional policies, and ethical standards governing human subjects research. All serious adverse events, unanticipated problems, regulatory submissions, and required reports shall be submitted in writing to the Reviewing Body within the timeframes required by that body. Any amendment to the Protocol that materially alters risks, consent, procedures, or data handling must be submitted for review and approval prior to implementation, unless immediate implementation is necessary to eliminate an immediate hazard to participants.

Governing Law

This Protocol shall be governed by and construed in accordance with the laws of the jurisdiction of , without regard to conflict of law principles.

Entire Agreement; Severability

This Protocol, including any attachments and approved amendments, constitutes the entire agreement between the parties with respect to the subject matter herein and supersedes all prior and contemporaneous understandings. If any provision of this Protocol is held invalid or unenforceable, the remaining provisions shall remain in full force and effect.

Conflict of Interest Disclosure

The Principal Investigator affirms that all financial interests, relationships, or activities that could reasonably appear to affect the design, conduct, or reporting of the research have been disclosed to the Reviewing Body. Disclosed conflicts shall be managed in accordance with institutional policy.

Acknowledgment

By signing below, the parties certify that they have read and understand this Protocol and agree to perform their obligations in accordance with applicable law, institutional policy and the terms set forth herein.

Principal Investigator (Print Name):

By:

Date:

Title / Role:

Authorized Institutional Official (Print Name):

By:

Date:

Title / Role:

What a Research Review Protocol Is and When It Applies

A Research Review Protocol is a structured document that describes a study's objectives, design, participant eligibility, methodology, data management, and risk-mitigation measures. Institutions and review boards use it to assess scientific validity, participant safety, and regulatory compliance before a study begins. The protocol typically includes background, aims, detailed procedures, statistical plans, informed consent processes, privacy protections, and monitoring plans to ensure ethical conduct and reproducible results.

Why a Clear Protocol Matters for Review and Compliance

A complete Research Review Protocol streamlines institutional review, clarifies responsibilities, and documents protections for participants and data. It reduces review cycles, supports consistent ethical decisions, and creates an auditable record that investigators and sponsors can rely on during monitoring or regulatory inspection.

Primary Users and Stakeholders Involved

The Research Review Protocol is prepared and used by a mix of investigators, sponsors, and institutional personnel to support review and oversight.

Principal Investigators — Draft and ensure protocol accuracy before submission to the institutional review board.
IRB/Research Ethics Committees — Evaluate risks, consent language, and safeguards during formal review.
Study Coordinators and Data Managers — Implement procedures and maintain required records during study conduct.

Clear role definitions in the protocol reduce ambiguity during review, help prioritize required revisions, and speed approvals across institutional workflows.

Core Sections Every Professional Protocol Should Include

A professional Research Review Protocol follows a consistent structure so reviewers can locate critical information quickly. Each section should be explicit about responsibilities, timing, and compliance controls.

Study Overview

Background, objectives, hypotheses, and primary/secondary endpoints explained with rationale and scientific context to justify study design and sample size.

Methods

Study design, population, inclusion/exclusion criteria, randomization (if any), procedures, interventions, and detailed visit schedules for reproducibility.

Safety Monitoring

Adverse event definitions, reporting pathways, stopping rules, data safety monitoring board roles, and participant protection measures.

Data Management

Data collection instruments, storage locations, de-identification, access controls, retention policies, and plans for data sharing or archiving.

Informed Consent

Consent form text, assent procedures for minors, consent process description, and language covering electronic consent or remote signing when used.

Statistical Plan

Sample size calculation, analysis populations, handling of missing data, interim analyses, and criteria for final analysis and reporting.

Essential Data Elements to Include

Protocol ID: Unique identifier for tracking

Principal Investigator: Name and institutional affiliation

Funding Source: Sponsor or grant reference

IRB Number: Assigned review identifier

Effective Dates: Start and expected end dates

Version History: Amendments and version notes

Step-by-Step: Preparing and Submitting the Protocol

Follow these sequential steps to prepare a submission-ready Research Review Protocol that meets institutional and regulatory expectations.

01

Draft Content: Assemble study background, methods, consent, and safety plans.
02

Internal Review: Obtain departmental sign-off and legal or grants office review.
03

IRB Submission: Upload documents, complete required forms, and answer review questions.
04

Post-Approval Actions: Implement monitoring, training, and record retention as required.

Configuring an Online Review Workflow for the Protocol

When completing the protocol in an electronic system, set up fields, routing, and authentication so submissions flow automatically to reviewers and archives.

Field Mapping	Map protocol fields to the IRB intake form for auto-population
Conditional Fields	Enable conditional questions that appear based on study type
Routing Rules	Assign reviewer queues by department and risk level
Signer Authentication	Require institutional SSO or multi-factor for approvers
Archive Settings	Set retention and export rules for finalized protocols

Where to Send, File, and Archive the Final Protocol

A clear routing path ensures reviewers can access documents and investigators can implement approved procedures without delay.

IRB Submission: Upload final protocol and consent forms to the IRB portal.
Sponsor Archive: Send signed copies to the study sponsor or funding office.
Institutional Records: Store signed protocol in the institutional document repository.
Participant Files: Place consent forms in secure participant records as required.

Digital Signing and eSubmission Requirements

Use an eSubmission platform that supports secure signing, authentication, and auditable logs to meet institutional policies and regulatory expectations.

File Formats: PDF or DOCX preferred
Authentication: SSO or MFA for approvers
Integrations: Connects to document storage

Ensure the selected system can produce a tamper-evident signed PDF, an audit trail with timestamps and IP addresses, and supports integrations with institutional repositories and eIRB platforms.

Typical Timelines and Expected Processing Intervals

Processing times vary by institution and review type; plan submissions to accommodate review cycles and possible revisions.

Initial Submission Window:

Submit at least 4 weeks before planned start for full-board review

Expedited Review:

Smaller minimal-risk studies may be reviewed within 1–2 weeks

Continuing Review:

Annual progress reports typically required every 12 months

Amendment Review:

Amendments usually processed within 2–4 weeks

Closeout Processing:

Final reports and data archiving after study completion may take 2–6 weeks

Key Milestones from Draft to Activation

A milestone view helps teams coordinate tasks and track approval progress from drafting through study activation.

01

Protocol Drafting

Complete full protocol content, attachments, and informed consent templates.

02

Institutional Review

Internal reviewers and compliance offices check regulatory alignment and completeness.

03

IRB Decision

IRB issues approval, conditional approval, or requests modifications.

04

Study Activation

Implement training, finalize documents, and begin participant enrollment.

Common Preparation Mistakes to Avoid

Unclear inclusion criteria lead to enrollment delays and reviewer questions that prolong approval cycles.
Incomplete safety monitoring plans increase perceived risk and often trigger conditional approvals or requests for more detail.
Mismatched names or missing signatures on authorization pages cause administrative rejections and resubmissions.
Insufficient data management detail about de-identification and access controls raises privacy concerns during review.

Consequences of an Incomplete or Noncompliant Protocol

Approval Delays: Study cannot begin

Conditional Approval: Requires changes before enrollment

Funding Risk: Sponsor requirements unmet

Data Integrity: Questions about validity

Regulatory Action: Potential citations or restrictions

Participant Harm: Increased safety risk

Typical eSignature Pricing and Feature Comparison for Protocol Signing

Compare baseline pricing and key capabilities for eSignature vendors commonly used for protocol signing and institutional workflows.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies	Varies	Varies	Varies
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No

Frequently Asked Questions About Using and Signing the Protocol

Answers to common questions about legality, e-signing, amendments, witnesses, and storage for Research Review Protocols.

Need help? Contact support

Can a protocol be signed electronically?
Yes. Electronic signatures are legally recognized under the federal ESIGN Act (15 U.S.C. ch. 96) and by UETA in most states, provided the signature shows intent, consent, attribution, and record retention.
When is notarization required?
Most protocols do not require notarization, but specific institutional or sponsor requirements may. If a notarized signature is requested, follow state rules and consider Remote Online Notarization where allowed.
What if the IRB requests amendments?
Submit an amendment with tracked changes and a cover memo. Include revised consent forms, a redline of changes, and a rationale to minimize review time.
How long must the protocol be retained?
Retain the final protocol and all versions per institutional policy, generally at least 3 years after study close; HIPAA and other rules may require 6 or more years.
Who may sign the protocol?
Authorized signatories typically include the principal investigator, department chair, and institutional official; list required signers in the protocol and follow institutional delegation logs.
Is eConsent acceptable for participants?
Electronic consent is permitted when it meets ESIGN/UETA requirements and institutional policies; consumer-disclosure elements and the ability to provide a paper copy when requested may be required for some studies.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now